Status:
RECRUITING
Secondary Prevention With the Lifestyle Tool
Lead Sponsor:
Region Skane
Conditions:
Cardiovascular Diseases
Eligibility:
All Genders
35-80 years
Phase:
NA
Brief Summary
In this study participants will be randomized to use a digital lifestyle tool over three years or to a control group without access to the tool. The investigators will prospectively follow the inciden...
Detailed Description
Cardiovascular disease (CVD) remains a leading cause of death in most European countries, and new strategies for prevention are urgently needed. Previous studies on primary and secondary prevention h...
Eligibility Criteria
Inclusion
- age 35 to 80 years
- myocardial infarction within one year prior to enrolment
- access to computer or mobile phone.
Exclusion
- conditions or treatments that in the judgement of the Investigator could affect the study evaluation
Key Trial Info
Start Date :
April 6 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
11000 Patients enrolled
Trial Details
Trial ID
NCT05309876
Start Date
April 6 2022
End Date
December 31 2028
Last Update
July 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Skane University Hospital
Malmo, Sweden, 20502